AMPOLLINI, Luca
 Distribuzione geografica
Continente #
EU - Europa 10.266
NA - Nord America 7.030
AS - Asia 4.329
SA - Sud America 580
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 22.281
Nazione #
US - Stati Uniti d'America 6.944
IT - Italia 5.406
CN - Cina 1.787
SG - Singapore 1.364
IE - Irlanda 1.065
SE - Svezia 798
FI - Finlandia 760
HK - Hong Kong 603
FR - Francia 523
BR - Brasile 521
DE - Germania 490
NL - Olanda 385
TR - Turchia 283
UA - Ucraina 264
GB - Regno Unito 179
IN - India 103
AT - Austria 77
RU - Federazione Russa 73
CA - Canada 60
BE - Belgio 54
BD - Bangladesh 39
CH - Svizzera 37
CZ - Repubblica Ceca 35
AR - Argentina 23
ES - Italia 21
PL - Polonia 21
CI - Costa d'Avorio 19
MX - Messico 16
DK - Danimarca 15
IQ - Iraq 14
ZA - Sudafrica 14
IR - Iran 13
PK - Pakistan 13
LT - Lituania 12
VN - Vietnam 12
ID - Indonesia 10
JP - Giappone 10
MA - Marocco 10
RO - Romania 10
UZ - Uzbekistan 10
VE - Venezuela 10
CO - Colombia 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
SA - Arabia Saudita 7
CL - Cile 6
IL - Israele 6
AU - Australia 5
BG - Bulgaria 5
EC - Ecuador 5
EG - Egitto 5
EU - Europa 5
GR - Grecia 5
TN - Tunisia 5
JO - Giordania 4
KR - Corea 4
KZ - Kazakistan 4
LK - Sri Lanka 4
LU - Lussemburgo 4
PA - Panama 4
PH - Filippine 4
PT - Portogallo 4
SI - Slovenia 4
TW - Taiwan 4
BO - Bolivia 3
KE - Kenya 3
NG - Nigeria 3
RS - Serbia 3
SN - Senegal 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HR - Croazia 2
HU - Ungheria 2
KH - Cambogia 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
PY - Paraguay 2
TH - Thailandia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BT - Bhutan 1
CR - Costa Rica 1
ET - Etiopia 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NO - Norvegia 1
Totale 22.279
Città #
Chandler 1.199
Dublin 1.063
Singapore 845
Ashburn 621
Hong Kong 595
Santa Clara 532
Beijing 466
Milan 355
Ann Arbor 351
Dearborn 324
Boardman 301
Rome 292
Parma 278
Izmir 253
Nanjing 249
Jacksonville 207
Princeton 205
New York 202
Shanghai 167
Munich 137
Wilmington 120
Bologna 95
Helsinki 95
San Mateo 95
Jinan 88
Chicago 81
Seattle 80
Shenyang 78
Kunming 76
Bremen 75
Columbus 75
Naples 74
Los Angeles 70
Nanchang 66
Hefei 65
Turin 62
Hebei 58
Vienna 56
Brussels 51
Guangzhou 49
Des Moines 46
Florence 45
Moscow 45
Jiaxing 44
Catania 43
Padova 43
Palermo 40
Rio Saliceto 40
Napoli 39
Changsha 34
Genoa 34
São Paulo 34
Turku 34
Houston 33
Tianjin 33
Toronto 33
Bari 32
Fremont 31
Dallas 29
Genova 29
London 28
Woodbridge 27
Nuremberg 26
The Dalles 26
Brescia 25
Düsseldorf 25
Norwalk 25
Perugia 25
Frankfurt am Main 23
Belo Horizonte 22
Modena 22
Zhengzhou 21
Torino 20
Abidjan 19
Pisa 19
Reggio Emilia 18
Augusta 17
Chengdu 17
Hangzhou 16
Council Bluffs 15
Monza 15
Pescara 15
Verona 15
Paris 14
Warsaw 14
Crema 13
Haikou 13
Pune 13
Rio de Janeiro 13
Amsterdam 12
Brno 12
Chongqing 12
Falls Church 12
Fuzhou 12
Kocaeli 12
Livorno 12
Monmouth Junction 12
Redwood City 12
Salerno 12
Leawood 11
Totale 11.584
Nome #
EVOLUZIONE ATIPICA DI UN CASO DI LEIOMIOMA METASTATIZZANTE BENIGNO POLMONARE 2.271
TUMORE FIBROSO SOLITARIO MALIGNO DELLA PLEURA ASSOCIATO A SEVERA IPOGLICEMIA: LA SINDROME DI DOEGE-POTTER 1.687
Aerostasi in chirurgia toracica nell’Azienda Ospedaliero-Universitaria di Parma: introduzione nella pratica clinica del Tachosil, un sigillante registrato come farmaco 993
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 466
Diverticolo tracheale acquisito: una rara causa di emottisi 383
LINFOCITI INFILTRANTI IL TUMORE, BAP-1, VEGFR-2 E IGF-1R NEL MESOTELIOMA PLEURICO MALIGNO 218
A comparison between the effects of over-expression of miRNA-16 and miRNA-34a on cell cycle progression of mesothelioma cell lines and on their cisplatin sensitivity 172
Fistola tracheo-esofagea congenita di tipo “H” nell’adulto 170
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 170
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 151
Hydrogen sulfide inhibits tmprss2 in human airway epithelial cells: Implications for sars‐cov‐2 infection 150
Adenocarcinoma associato a melanoma amelanotico primario dell’esofago distale 142
Leiomioma metastatizzante benigno gigante 142
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 141
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 138
Intrapleural polymeric devices containing Cisplatin for malignant pleural Mesothelioma in a rat tumor model: a preliminary study. 134
Solid-phase microextraction coupled to gas chromatography mass spectrometry followed by multivariate data analysis for the identification of volatile organic compounds as possible biomarkers in lung cancer tissues 132
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 126
PREDICTIVE AND PROGNOSTIC VALUE OF CLINICAL AND MOLECULAR FEATURES IN PATIENTS UNDERGOING PULMONARY METASTASECTOMY FROM RENAL CELL CARCINOMA 125
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 124
Lipoma endobronchiale: una rara causa di ostruzione bronchiale 121
CARCINOMA NEUROENDOCRINO PRIMITIVO DEL MEDIASTINO 121
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 120
Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection 119
Intraoperative Endobronchial swab after major lung resection: does it influence the course of postoperative pulmonary infections ? 117
Lung metastasis resection of adenoid cystic carcinoma of salivary glands 116
Exhaled breath analysis in suspected cases of non-small-cell lung cancer: a cross-sectional study 116
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 115
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 115
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 115
Pulmonary metastasectomy for colorectal cancer: Analysis of prognostic factors affecting survival 113
MEDIASTINITE FIBROSANTE ASSOCIATA A GRNULOMATOSI DI WEGENER 112
Intrapleural adjuvant treatment of mesothelioma : The combination of cisplatin-pemetrexed in rat tumor model 112
Isolation and characterization of human lung lymphatic endothelial cells 111
Antitumoral effect of a nanotechnology-based photodynamic therapy. 111
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 110
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 108
Linezolid-induced black hairy tongue 106
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 104
Neoplasie del polmone in Neoplasie del Distretto Toracico 104
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 104
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 103
Cardiac autonomic and cortisol stress responses to real operations in surgeons: relationship with individual psychobiological characteristics and experience 102
Physico-chemical characterization and biological evaluation of two fibroin materials 101
INTRAPLEURAL POLYMERIC FILMS CONTAINING CISPLATIN FOR MALIGNANT PLEURAL MESOTHELIOMA: PRELIMINARY PHARMACOKINETIC DATA IN AN OVINE MODEL 101
IASLC and WHO 2004 Grading System as Prognostic Factors in 492 Cases of Pulmonary Adenocarcinoma 101
The role of miRNA-221 and miRNA-126 in patients with benign metastasizing leiomyoma of the lung: an overview with new interesting scenarios 100
Conversion due to vascular injury during video-assisted thoracic surgery lobectomy: A multicentre retrospective analysis from the Italian video-assisted thoracic surgery group registry 99
Predictive factors of diagnostic accuracy of CT-guided transthoracic fine-needle aspiration for solid noncalcified, subsolid and mixed pulmonary nodules. 99
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma 99
Cardiac tanponade in patient vith thoraco-abdominal aortic aneurysm 98
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 98
A huge ulcerated mass of the thorax 98
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 97
227P Sexual dimorphism in immune profile of early and advanced NSCLC 96
Prognostic value of [18F]FDG PET/CT parameters in surgically resected primary lung adenocarcinoma: a single-center experience 96
Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study) 94
A prospective, randomized, blinded comparison between continuous thoracic paravertebral and epidural infusion of 0.2% ropivacaine after lung resection surgery 94
Giant intercostal nerve schwannoma in a patient with neurofibromatosis type 2 93
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 93
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 93
Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer 92
Posterior mediastinal myelolipoma resected by video-assisted thoracic surgery 91
A novel method of tracheoesophageal fistula closure 90
Unusual case of giant typical carcinoid tumor 90
Intrapleural application of polymeric films containing cisplatin and pemetrexed in a rat tumour model of malignant pleural mesothelioma 90
SURGICAL SAMPLING IS AN EMERGING ISSUE IN THE ASSESSMENT OF THE IMMUNE CONTEXTURE IN NON SMALL CELL LUNG CANCER (NSCLC) 90
Metastasectomia polmonare secondaria a tumore renale (RCC). Esperienza di Parma 89
The value of lung metastases resection from adenoid cystic carcinoma 89
Abdominal visceral hernia through a chest wall defect secondary to open-window thoracostomy 88
Cavernous hemangioma of the posterior mediastinum 88
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 87
Multiple primary malignancies involving lung cancer: a single-center experience 87
Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids 86
Resection of giant typical carcinoid tumor with cardiopulmonary bypass support. 86
Post-pneumonectomy cavity: is there still a cavity? 86
Insolita evoluzione della cavità pleurica dopo pneumonectomia destra 85
Chirurgia per carcinoma mammario con modalità day- o one-day surgery: un’esperienza di 12 anni 85
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 85
Long-lasting tuberculous pleurisy 85
Exercise capacity assessment in patients undergoing lung resection 85
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 85
YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis. 84
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 84
METACHRONOUS AND SYNCHRONOUS OCCURRENCE OF PRIMARY MALIGNANCIES IN PATIENTS WITH RESECTED NON SMALL CELL LUNG CANCER (NSCLC): A RETROSPECTIVE OBSERVATIONAL STUDY 84
EXCEPTIONAL EVOLUTION OF BENIGN METASTASIZING LEIOMYOMAS OF THE LUNG 84
An unusual case of thoracic calcifyng fibrous pseudotumor 83
Multicenter experience of resected thymic epithelial tumors (TETs): an observational report on behalf of FONICAP (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone) 82
Primary atypical carcinoid tumor of the mediastinum: A very rare finding 82
Metaplastic carcinoma spindle-cell type of the breast 81
Postoperative Subconjunctival Emphysema 81
Prophylactic Use of Helmet-CPAP After Pulmonary Lobectomy: A Prospective Randomized Controlled Study. 80
Longitudinal evolution of incidentally detected solitary pure ground-glass nodules on ct: Relation to clinical metrics 80
Ground glass nodules evolution according with an history of tumour 80
TUMOR-INFILTRATING LYMPHOCYTES, PDL-1, BAP-1, VEGFR-2 AND IGF-1R EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA 80
DIAPHRAGMATIC LACERATION PARTIAL LIVER HERNIATION AND CATAMENIAL PNEUMOTHORAX 80
Cutaneous verroucous carcinoma presenting as a huge ulcerated mass of the thorax 80
INTRAPLEURAL POLYMERIC FILMS LOADED WITH CISPLATIN FOR MALIGNANT PLEURAL MESOTHELIOMA: PRELIMINARY PHARMACOKINETIC DATA IN AN OVINE MODEL 80
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies 79
Placental Transmogrification of the Lung Presenting as a Giant Bulla Associated with a Pulmonary Hamartoma 79
Totale 15.662
Categoria #
all - tutte 76.376
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.376


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.660 58 110 97 126 207 126 142 104 229 103 253 105
2021/20221.436 85 72 92 104 51 60 158 132 91 114 63 414
2022/20234.819 422 518 282 366 375 554 142 351 1.367 70 264 108
2023/20242.534 179 223 101 94 198 471 195 195 148 175 195 360
2024/20255.736 177 344 400 302 579 554 274 249 798 532 543 984
2025/2026603 603 0 0 0 0 0 0 0 0 0 0 0
Totale 22.614